ResMed (RMD) PT Lowered to $255 at Mizuho
Get Alerts RMD Hot Sheet
Price: $229.19 -0.73%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Mizuho analyst Anthony Petrone lowered the price target on ResMed (NYSE: RMD) to $255.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- ResMed (RMD) PT Raised to $267 at KeyBanc Following Last Week's NDR
- Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer
- Frazier Healthcare buys MatrixCare from ResMed, names new CEO
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share